These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 26973412)
1. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. Sarkar A; De R; Mukhopadhyay AK World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412 [TBL] [Abstract][Full Text] [Related]
2. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases. Mohammadi A; Khanbabaei H; Zandi F; Ahmadi A; Haftcheshmeh SM; Johnston TP; Sahebkar A Microb Pathog; 2022 May; 166():105552. PubMed ID: 35469998 [TBL] [Abstract][Full Text] [Related]
3. Review: Pharmacological ins and outs of medicinal plants against Helicobacter pylori: A review. Zaidi SF; Muhammad JS; Usmanghani K; Sugiyama T Pak J Pharm Sci; 2015 May; 28(3 Suppl):1171-6. PubMed ID: 26051742 [TBL] [Abstract][Full Text] [Related]
4. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. Sokic-Milutinovic A; Alempijevic T; Milosavljevic T World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention for gastric cancer. Ford AC Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):581-92. PubMed ID: 22122773 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Koosirirat C; Linpisarn S; Changsom D; Chawansuntati K; Wipasa J Int Immunopharmacol; 2010 Jul; 10(7):815-8. PubMed ID: 20438867 [TBL] [Abstract][Full Text] [Related]
7. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. Foryst-Ludwig A; Neumann M; Schneider-Brachert W; Naumann M Biochem Biophys Res Commun; 2004 Apr; 316(4):1065-72. PubMed ID: 15044093 [TBL] [Abstract][Full Text] [Related]
8. Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication. Park SH; Kangwan N; Park JM; Kim EH; Hahm KB World J Gastroenterol; 2013 Dec; 19(47):8986-95. PubMed ID: 24379623 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Helicobacter pylori and prevention of gastric cancer. Cheung TK; Wong BC J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788 [TBL] [Abstract][Full Text] [Related]
10. Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling. Su T; Li F; Guan J; Liu L; Huang P; Wang Y; Qi X; Liu Z; Lu L; Wang D Phytomedicine; 2019 Oct; 63():152968. PubMed ID: 31280140 [TBL] [Abstract][Full Text] [Related]
11. The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal. Wu JY; Lee YC; Graham DY Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):17-24. PubMed ID: 30791844 [TBL] [Abstract][Full Text] [Related]
12. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Di Mario F; Cavallaro LG; Nouvenne A; Stefani N; Cavestro GM; Iori V; Maino M; Comparato G; Fanigliulo L; Morana E; Pilotto A; Martelli L; Martelli M; Leandro G; Franzè A Helicobacter; 2007 Jun; 12(3):238-43. PubMed ID: 17493004 [TBL] [Abstract][Full Text] [Related]
13. [The "stomach evil" Helicobacter pylori: also stomach cancer is usually accredited to Helicobacter pylori]. MMW Fortschr Med; 2004 Jun; 146(24):54. PubMed ID: 15366502 [No Abstract] [Full Text] [Related]
14. The antibacterial effect of fatty acids on Helicobacter pylori infection. Jung SW; Lee SW Korean J Intern Med; 2016 Jan; 31(1):30-5. PubMed ID: 26767854 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis. Shao Y; Sun K; Xu W; Li XL; Shen H; Sun WH World J Gastroenterol; 2014 Sep; 20(36):12860-73. PubMed ID: 25278683 [TBL] [Abstract][Full Text] [Related]
16. Turmeric and curcumin as adjuncts in controlling Helicobacter pylori-associated diseases: a narrative review. Boyanova L; Medeiros J; Yordanov D; Gergova R; Markovska R Lett Appl Microbiol; 2024 Jun; 77(6):. PubMed ID: 38794899 [TBL] [Abstract][Full Text] [Related]
17. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Mahady GB; Pendland SL; Yun G; Lu ZZ Anticancer Res; 2002; 22(6C):4179-81. PubMed ID: 12553052 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. De R; Kundu P; Swarnakar S; Ramamurthy T; Chowdhury A; Nair GB; Mukhopadhyay AK Antimicrob Agents Chemother; 2009 Apr; 53(4):1592-7. PubMed ID: 19204190 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies. Vogiatzi P; Cassone M; Luzzi I; Lucchetti C; Otvos L; Giordano A J Cell Biochem; 2007 Oct; 102(2):264-73. PubMed ID: 17486575 [TBL] [Abstract][Full Text] [Related]